J. Lenders, G. Eisenhofer, M. Mannelli, and K. Pacak, Phaeochromocytoma, The Lancet, vol.366, issue.9486, pp.665-675, 2005.
DOI : 10.1016/S0140-6736(05)67139-5

P. Dahia, Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity, Nature Reviews Cancer, vol.285, issue.2, pp.108-119, 2014.
DOI : 10.1038/nrc3648

A. Gimenez-roqueplo, P. Dahia, and M. Robledo, An Update on the Genetics of Paraganglioma, Pheochromocytoma, and Associated Hereditary Syndromes, Hormone and Metabolic Research, vol.44, issue.05, pp.328-333, 2012.
DOI : 10.1055/s-0031-1301302

J. Crona, D. Verdugo, A. Maharjan, R. Stalberg, P. Granberg et al., Somatic Mutations in H-RAS in Sporadic Pheochromocytoma and Paraganglioma Identified by Exome Sequencing, J Clin Endocrinol Metab, 2013.

E. Letouze, C. Martinelli, C. Loriot, N. Burnichon, N. Abermil et al., SDH Mutations Establish a Hypermethylator Phenotype in Paraganglioma, Cancer Cell, vol.23, issue.6, pp.739-752, 2013.
DOI : 10.1016/j.ccr.2013.04.018

F. Lorenzo, C. Yang, N. Tang-fui, M. Vankayalapati, H. Zhuang et al., A novel EPAS1/HIF2A germline mutation in a congenital polycythemia with paraganglioma, Journal of Molecular Medicine, vol.359, issue.4, p.2012
DOI : 10.1007/s00109-012-0967-z

P. Dahia, K. Ross, M. Wright, C. Hayashida, S. Santagata et al., A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas, PLoS Genet, vol.1, pp.72-80, 2005.

J. Welander, P. Soderkvist, and O. Gimm, Genetics and clinical characteristics of hereditary pheochromocytomas and paragangliomas, Endocrine Related Cancer, vol.18, issue.6, pp.253-276, 2011.
DOI : 10.1530/ERC-11-0170

M. Ayala-ramirez, L. Feng, M. Johnson, S. Ejaz, M. Habra et al., Clinical Risk Factors for Malignancy and Overall Survival in Patients with Pheochromocytomas and Sympathetic Paragangliomas: Primary Tumor Size and Primary Tumor Location as Prognostic Indicators, The Journal of Clinical Endocrinology & Metabolism, vol.96, issue.3, pp.717-725, 2011.
DOI : 10.1210/jc.2010-1946

A. Ronald, R. Delellis, P. Heitz, and C. Eng, Pathology and genetics of tumours of Endocrine Organs, 2004.

A. Tischler, Pheochromocytoma and extra-adrenal paraganglioma: updates, Arch Pathol Lab Med, vol.132132, pp.1272-1284, 1272.

G. Eisenhofer, A. Tischler, and R. De-krijger, Diagnostic Tests and Biomarkers for Pheochromocytoma and Extra-adrenal Paraganglioma: From Routine Laboratory Methods to Disease Stratification, Endocrine Pathology, vol.2, issue.1, pp.4-14, 2012.
DOI : 10.1007/s12022-011-9188-1

E. Elder, D. Xu, A. Hoog, U. Enberg, P. Pisa et al., KI-67 AND hTERT Expression Can Aid in the Distinction between Malignant and Benign Pheochromocytoma and Paraganglioma, Modern Pathology, vol.16, issue.3, pp.246-255, 2003.
DOI : 10.1097/01.MP.0000056982.07160.E3

C. August, K. August, S. Schroeder, H. Bahn, R. Hinze et al., CGH and CD 44/MIB-1 immunohistochemistry are helpful to distinguish metastasized from nonmetastasized sporadic pheochromocytomas, Modern Pathology, vol.90, issue.9, pp.1119-1128, 2004.
DOI : 10.1038/modpathol.3800160

L. Thompson, Pheochromocytoma of the Adrenal Gland Scaled Score (PASS) to Separate Benign From Malignant Neoplasms, The American Journal of Surgical Pathology, vol.26, issue.5, pp.551-566, 2002.
DOI : 10.1097/00000478-200205000-00002

D. Wu, A. Tischler, R. Lloyd, R. Delellis, R. De-krijger et al., Observer Variation in the Application of the Pheochromocytoma of the Adrenal Gland Scaled Score, The American Journal of Surgical Pathology, vol.33, issue.4, pp.599-608, 2009.
DOI : 10.1097/PAS.0b013e318190d12e

N. Kimura, N. Takizawa, E. Itagaki, T. Katabami, N. Kakoi et al., Pathologic grading for predicting metastasis in phaeochromocytoma and paraganglioma, Endocr Relat Cancer, 2014.

J. Favier, P. Plouin, P. Corvol, and J. Gasc, Angiogenesis and Vascular Architecture in Pheochromocytomas, The American Journal of Pathology, vol.161, issue.4, pp.1235-1246, 2002.
DOI : 10.1016/S0002-9440(10)64400-8

R. Lloyd, A. Tischler, N. Kimura, A. Mcnicol, and J. Young, Adrenal tumours: Introduction, editor. WHO Classification of tumours-Pathology and Genetics-Tumours of endocrine organs, 2004.

J. Lenders, Q. Duh, G. Eisenhofer, A. Gimenez-roqueplo, S. Grebe et al., Pheochromocytoma and Paraganglioma: An Endocrine Society Clinical Practice Guideline, The Journal of Clinical Endocrinology & Metabolism, vol.99, issue.6, pp.1915-1942, 2014.
DOI : 10.1210/jc.2014-1498

F. Feng, Y. Zhu, X. Wang, Y. Wu, W. Zhou et al., Predictive Factors for Malignant Pheochromocytoma: Analysis of 136 Patients, The Journal of Urology, vol.185, issue.5, pp.1583-1589, 2011.
DOI : 10.1016/j.juro.2010.12.050

Q. Liu, G. Djuricin, E. Staren, P. Gattuso, V. Gould et al., Tumor angiogenesis in pheochromocytomas and paragangliomas, Surgery, vol.120, issue.6, pp.938-942, 1996.
DOI : 10.1016/S0039-6060(96)80037-7

P. Rooijens, D. Krijger, R. Bonjer, H. Van-der-ham, F. Nigg et al., The Significance of Angiogenesis in Malignant Pheochromocytomas, Endocrine Pathology, vol.15, issue.1, pp.39-45, 2004.
DOI : 10.1385/EP:15:1:39

A. Zielke, M. Middeke, S. Hoffmann, M. Colombo-benkmann, P. Barth et al., VEGF-mediated angiogenesis of human pheochromocytomas is associated to malignancy and inhibited by anti-VEGF antibodies in experimental tumors, Surgery, vol.132, issue.6, pp.1056-1063, 2002.
DOI : 10.1067/msy.2002.128613

H. Ohji, I. Sasagawa, O. Iciyanagi, Y. Suzuki, and T. Nakada, Tumour angiogenesis and Ki-67 expression in phaeochromocytoma, BJU International, vol.191, issue.4, pp.381-385, 2001.
DOI : 10.1046/j.1464-410x.2001.00102.x